Literature DB >> 15761594

Seroprevalence of Trypanosoma cruzi infection in French Guiana.

Christine Aznar1, Guy La Ruche, Stéphane Laventure, Bernard Carme, Pascale Liegeard, Mireille Hontebeyrie.   

Abstract

A survey was carried out on 1487 individuals to assess the seroprevalence of Trypanosoma cruzi infection in French Guiana. The overall prevalence of T. cruzi specific IgG was 0.5%. In multivariate analysis, residence in areas where housing is favorable for the presence of triatomine bugs was the only factor associated with the presence of T. cruzi antibodies. These results have implications for public health since blood donors are not routinely screened for T. cruzi infection in French Guiana.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15761594     DOI： 10.1590/s0074-02762004000800004

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


  6 in total

1.  Alloimmunization in patients with sickle cell disease in French Guiana.

Authors:  Narcisse Elenga; Loic Niel
Journal:  J Blood Transfus       Date:  2015-02-02

2.  Amazonian Triatomine Biodiversity and the Transmission of Chagas Disease in French Guiana: In Medio Stat Sanitas.

Authors:  Julie Péneau; Anne Nguyen; Alheli Flores-Ferrer; Denis Blanchet; Sébastien Gourbière
Journal:  PLoS Negl Trop Dis       Date:  2016-02-11

3.  Clinical Features, Diagnosis, and Outcome of Encephalitis in French Guiana.

Authors:  Alexandre Roux; Stéphanie Houcke; Alice Sanna; Cyrille Mathien; Claire Mayence; Romain Gueneau; Geoffroy Liegeon; Gaelle Walter; Dabor Resiere; Narcisse Elenga; Géraldine Resin; Felix Djossou; Didier Hommel; Hatem Kallel
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

4.  Increased Prevalence of Alloimmunization in Sickle Cell Disease? Should We Restore Blood Donation in French Guiana?

Authors:  Salomé Conrath; Vincent Vantilcke; Mickael Parisot; Françoise Maire; Pierre Selles; Narcisse Elenga
Journal:  Front Med (Lausanne)       Date:  2021-06-11

5.  Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease.

Authors:  Armand Berneman; Lory Montout; Sophie Goyard; Nathalie Chamond; Alain Cosson; Simon d'Archivio; Nicolas Gouault; Philippe Uriac; Arnaud Blondel; Paola Minoprio
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

6.  Triatominae species of Suriname (Heteroptera: Reduviidae) and their role as vectors of Chagas disease.

Authors:  Hélène Hiwat
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-07-03       Impact factor: 2.743
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.